Somewhat Positive Media Coverage Somewhat Unlikely to Impact Medical Properties Trust (MPW) Share Price
Press coverage about Medical Properties Trust (NYSE:MPW) has been trending somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Medical Properties Trust earned a daily sentiment score of 0.16 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 46.8537673084906 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:
- Buyers and Sellers Alert — Medical Properties Trust, Inc. (MPW) – usstockjournal (usstockjournal.com)
- Relative Strength Alert For Medical Properties Trust – Nasdaq (nasdaq.com)
- Medical Properties Trust, Inc. (MPW) Receives Consensus Rating of “Hold” from Analysts (americanbankingnews.com)
- Are These Just A Random Activities? Medical Properties Trust, Inc. (MPW), AVeeva Systems Inc. (VEEV) – Market Movers (financialqz.com)
- Featured Volatile Stock – Medical Properties Trust Inc (NYSE: MPW) – Alpha Beta Stock (alphabetastock.com)
Several brokerages recently commented on MPW. Deutsche Bank downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating and dropped their price objective for the company from $14.00 to $13.50 in a research note on Wednesday, January 10th. JPMorgan Chase & Co. upgraded shares of Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price target for the company in a research report on Friday, December 15th. Zacks Investment Research upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, January 16th. Robert W. Baird cut shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $15.00 to $13.00 in a research report on Friday, January 5th. Finally, SunTrust Banks restated a “buy” rating and issued a $15.00 price target on shares of Medical Properties Trust in a research report on Friday, November 3rd. Eight research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $14.30.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.